Nanotechnology Now - Press Release: Nanobiotix Receives European Market APPROVAL for Cancer Therapy Hensify (NBTXR3)
| Date | 20th, Jul 2019 |
|---|---|
| Source | Nanotechnology Now - Nanotechnology Websites |
DESCRIPTION
· Hensify®(NBTXR3) received European market approval (CE mark) enabling commercialization in 27 European Union countries for the treatment of locally advanced soft tissue sarcoma
·...